Atacana Group > Resources Center > Reports > Navigating the Obesity Market: An Overview of Current and Future Trends
Dark Mode

Navigating the Obesity Market: An Overview of Current and Future Trends

05/09/2024
05/09/2024
Atacana Group
Author

Game-Changing Advancements Are Transforming The Obesity Drug Market

Growing market for obesity drugs expected to reach $100B by 2030



Major recent deals and acquisitions

NovoNordisk is at the forefront with 6 upcoming launches in the upcoming 5 years. EliLilly is making waves too, advancing the development of combinations and oral drugs. Other big pharma like AstraZeneca and Roche are recognizing the potential of the obesity drug market with deals and collaborations.

While injectable GIP/GLP-1 has garnered attention, leading companies acknowledge the imperative of adopting novel drug development approaches

Interested in diving deep into the catalysts report of the potential game-changers in the Obesity drug market. Download the report below.


Obesity 2024 Market Key Trends

Name*(Required)



Game-Changing Advancements Are Transforming The Obesity Drug Market

Growing market for obesity drugs expected to reach $100B by 2030



Major recent deals and acquisitions

NovoNordisk is at the forefront with 6 upcoming launches in the upcoming 5 years. EliLilly is making waves too, advancing the development of combinations and oral drugs. Other big pharma like AstraZeneca and Roche are recognizing the potential of the obesity drug market with deals and collaborations.

While injectable GIP/GLP-1 has garnered attention, leading companies acknowledge the imperative of adopting novel drug development approaches

Interested in diving deep into the catalysts report of the potential game-changers in the Obesity drug market. Download the report below.